A Phase Ia bridging study of AC-101 in China has also been finished. Dr. Xiaohu Zhang, co-founder and CEO of Accropeutics said, "We are thrilled to receive FDA clearance of IND for AC-101, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback